Gastroesophageal variceal bleeding

Descripción del Articulo

Massive upper gastrointestinal bleeding from ruptured gastroesophageal varices is the main complication of portal hypertension and represents a frequent cause of death and of liver transplantation in cirrhotic patients. Formation of varices is an almost unavoidable complication in cirrhosis. Varices...

Descripción completa

Detalles Bibliográficos
Autor: Velásquez Chamochumbi, Hermes
Formato: artículo
Fecha de Publicación:2024
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:amp.cmp.org.pe:article/1190
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/1190
Nivel de acceso:acceso abierto
Materia:Várices
Hemorragia gastrointestinal
Endoscopia
Varicose veins
Gastrointestinal bleeding
Endoscopy
id REVCMP_1aeaab79d2160297ea118b5e71556e03
oai_identifier_str oai:amp.cmp.org.pe:article/1190
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
dc.title.none.fl_str_mv Gastroesophageal variceal bleeding
Hemorragia digestiva por várices esófago - gástricas
title Gastroesophageal variceal bleeding
spellingShingle Gastroesophageal variceal bleeding
Velásquez Chamochumbi, Hermes
Várices
Hemorragia gastrointestinal
Endoscopia
Varicose veins
Gastrointestinal bleeding
Endoscopy
title_short Gastroesophageal variceal bleeding
title_full Gastroesophageal variceal bleeding
title_fullStr Gastroesophageal variceal bleeding
title_full_unstemmed Gastroesophageal variceal bleeding
title_sort Gastroesophageal variceal bleeding
dc.creator.none.fl_str_mv Velásquez Chamochumbi, Hermes
author Velásquez Chamochumbi, Hermes
author_facet Velásquez Chamochumbi, Hermes
author_role author
dc.subject.none.fl_str_mv Várices
Hemorragia gastrointestinal
Endoscopia
Varicose veins
Gastrointestinal bleeding
Endoscopy
topic Várices
Hemorragia gastrointestinal
Endoscopia
Varicose veins
Gastrointestinal bleeding
Endoscopy
description Massive upper gastrointestinal bleeding from ruptured gastroesophageal varices is the main complication of portal hypertension and represents a frequent cause of death and of liver transplantation in cirrhotic patients. Formation of varices is an almost unavoidable complication in cirrhosis. Varices are already present in about 40% of compensated asymptomatic patients at diagnosis, and the incidence increases to 90% of patients during long-term follow up. Variceal bleeding is the last step in a chain of events that starts with portal hypertension, followed by the development and growth of the varices, until they eventually bleed. In the Hospital Nacional Edgardo Rebagliati’s gastrointestinal bleeding unit, 18% of 8 365 admitted patients presented variceal rupture. The therapeutic options to stop the bleeding are divided into general and specific. The pharmacological therapy is addressed to reducing the increased intrahepatic resistance and blood flow. Terlipresin has demonstrated similar efficacy as endoscopic methods, and also as somastatin or octreotide. Sengstaken-Blackmore tubes are still helpful, mainly where no specialists are available. Sclerotherapy for esophageal varices, used since 1982 at our institution, is still the first line endoscopic therapy (96% of success in stopping bleeding). Esophageal varices Stents are the therapeutic option of choice to stop the bleeding, and they produce fewer complications than sclerotherapy. Success in treating bleeding esophageal varices will depend on the readiness of a specialized surgical-medical team that can take decisions in high alert situations.
publishDate 2024
dc.date.none.fl_str_mv 2024-05-22
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1190
url https://amp.cmp.org.pe/index.php/AMP/article/view/1190
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1190/665
dc.rights.none.fl_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol. 23 No. 3 (2006); 156 - 161
ACTA MEDICA PERUANA; Vol. 23 Núm. 3 (2006); 156 - 161
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1842710605998325760
spelling Gastroesophageal variceal bleedingHemorragia digestiva por várices esófago - gástricasVelásquez Chamochumbi, Hermes VáricesHemorragia gastrointestinalEndoscopiaVaricose veinsGastrointestinal bleedingEndoscopyMassive upper gastrointestinal bleeding from ruptured gastroesophageal varices is the main complication of portal hypertension and represents a frequent cause of death and of liver transplantation in cirrhotic patients. Formation of varices is an almost unavoidable complication in cirrhosis. Varices are already present in about 40% of compensated asymptomatic patients at diagnosis, and the incidence increases to 90% of patients during long-term follow up. Variceal bleeding is the last step in a chain of events that starts with portal hypertension, followed by the development and growth of the varices, until they eventually bleed. In the Hospital Nacional Edgardo Rebagliati’s gastrointestinal bleeding unit, 18% of 8 365 admitted patients presented variceal rupture. The therapeutic options to stop the bleeding are divided into general and specific. The pharmacological therapy is addressed to reducing the increased intrahepatic resistance and blood flow. Terlipresin has demonstrated similar efficacy as endoscopic methods, and also as somastatin or octreotide. Sengstaken-Blackmore tubes are still helpful, mainly where no specialists are available. Sclerotherapy for esophageal varices, used since 1982 at our institution, is still the first line endoscopic therapy (96% of success in stopping bleeding). Esophageal varices Stents are the therapeutic option of choice to stop the bleeding, and they produce fewer complications than sclerotherapy. Success in treating bleeding esophageal varices will depend on the readiness of a specialized surgical-medical team that can take decisions in high alert situations.El sangrado gastrointestinal superior masivo por ruptura de varices esófago-gástricas, es la principal complicación de la hipertensión portal y representa una causa frecuente de muerte o transplante de hígado en pacientes con cirrosis. La formación de várices es una complicación casi segura en cirrosis hepática. Ya desde el momento del diagnostico, las várices están presentes en el 40% de los pacientes compensados asintomáticos. Esta incidencia se incrementa hasta el 90% de pacientes con seguimiento a largo plazo. El sangrado por várices es el último paso en una cadena de eventos que es iniciada por el incremento de la presión portal, seguido del crecimiento y desarrollo de las varices y éstas finalmente sangran. En la Unidad de Hemorragia Digestiva del Hospital Rebagliati, de 8 365 pacientes admitidos por episodio agudo, el 18% fueron por ruptura de várices esofágicas. Las opciones terapéuticas para detener un sangrado por varices se dividen en medidas generales y específicas. La terapia farmacológica esta dirigida para reducir la resistencia intrahepática incrementada, asi como el flujo sanguíneo. La terlipresina ha demostrado efectos con resultrado.similares a los obtenidos por métodos endoscopicos, al igual que la somatostatina y su análogo sintético el octreotide. El uso de la sonda de Sengstaken-Blackmore es útil aun en el presente siglo, especialmente en medios que no cuentan con especialistas ni centros endoscópicos. La escleroterapia de las várices esófago-gástricas (EVE) que la realizamos desde 1982, sigue siendo en nuestro medio la terapia endoscópica de primera línea (96% cesan el sangrado) y la prevención de la recurrencia (10%). La endoligadura de várices esofágicas (ELVE) es también el método de elección para detener el sangrado por várices, con menos complicaciones que la escleroterapia. Finalmente el éxito en el tratamiento del sangrado por várices dependerá de la disponibilidad de un equipo medicoquirúrgico que tome decisiones en situaciones de “alerta roja”.Colegio Médico del Perú2024-05-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/1190ACTA MEDICA PERUANA; Vol. 23 No. 3 (2006); 156 - 161ACTA MEDICA PERUANA; Vol. 23 Núm. 3 (2006); 156 - 1611728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/1190/665Copyright (c) 2020 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:amp.cmp.org.pe:article/11902024-05-23T07:18:29Z
score 12.860855
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).